GSK Inks License Deal With China's Hansoh Pharma For HS-20093; To Pay Up To $1.7 Bln

GSK Reaches Confidential Settlement With Ronald Kimbrow Involving Ranitidine

GSK plc (GSK, GSK.L) announced Monday it has reached a confidential settlement with Ronald Kimbrow resolving the case he filed in Illinois state court. GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK.

RTTNews | 91 days ago

GSK Lifts FY23 Outlook As Q3 Profit From Cont. Opns Surges

British drug major GSK Plc on Wednesday lifted its fiscal 2023 forecast for earnings and sales after reporting higher third-quarter profit on continuing operations basis. The results were benefited by vaccines' performance, mainly the US launch of Arexvy, the world's first RSV vaccine. Total profit for the quarter, meanwhile, plunged from last year on the absence of prior year's hefty gain.

RTTNews | 362 days ago

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).

RTTNews | 433 days ago

GSK Begins Shipping Doses Of Quadrivalent Influenza Vaccines To US For 2023-24 Flu Season

GSK plc (GSK, GSK.L) announced Thursday it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2023-24 flu season.

RTTNews | 473 days ago

GSK, SCYNEXIS Ink Exclusive Licence Agreement For Brexafemme

GSK plc (GSK, GSK.L) and SCYNEXIS, Inc. (SCYX) announced Thursday they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and for reduction in the incidence of recurrent VVC (RVVC).

RTTNews | 578 days ago

FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis

The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval.

RTTNews | 634 days ago

FDA Approves GSK's Vaccine For Use In Pregnancy To Prevent Whooping Cough In Infants

The FDA has approved GSK plc's Boostrix vaccine for immunization during the third trimester of pregnancy to prevent pertussis, commonly known as whooping cough, in infants younger than two months of age. The agency noted that Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed [Tdap]), when given during pregnancy, boosts antibodies in the mother.

RTTNews | 749 days ago

CAC 40 Rallies After Israel's Calibrated Attack On Iran

French stocks rallied on Monday after Israel pounded Iran with a series of airstrikes early Saturday in retaliation for the barrage of ballistic missiles the Islamic Republic fired upon Israel on October 1.

RTTNews | 4h 11min ago

EURUSD	1.08172	GBPUSD	1.29712	AUDUSD	0.66042
USDJPY	153.15	USDCAD	1.38916	USDCHF	0.86733